Parkinson Hastalığında İlaç Etkinliğinin Biyobelirteçleri Olarak Delta-Beta ve Beta-Gamma Kaplin
Delta-Beta and Beta-Gamma Coupling as Biomarkers of Medication Efficacy in Parkinson's Disease
DOI: 10.21203/rs.3.rs-6476008/v1
Delta-Beta and Beta-Gamma Coupling as Biomarkers of Medication Efficacy in Parkinson's Disease
DOI: 10.21203/rs.3.rs-6476008/v1
A systematic review on autonomic dysfunctions in Parkinson’s disease
DOI: 10.21203/rs.3.rs-6621647/v1
Genetic basis of maneb-induced dopaminergic neurodegeneration in <i>Drosophila</i>
DOI: 10.1101/2025.05.07.652747
Lead Structure‐Based Hybridization Strategy Reveals Major Potency Enhancement of SirReal‐Type Sirt2 Inhibitors
DOI: 10.20944/preprints202505.0864.v1
Resonance-Frequency-Targeted High-Intensity Focused Ultrasound/Microwave for Selective Denaturation of Pathological Protein Aggregates in Neurodegenerative Diseases: A New Treatment Approach
DOI: 10.20944/preprints202505.0802.v1
Adherence to <i>a priori</i> and a posteriori dietary patterns and risk of Parkinson's disease: a systematic review and meta-analysis of observational studies.
DOI: 10.3389/fnut.2025.1600955PMID: 40421036
The key role of the ferroptosis mechanism in neurological diseases and prospects for targeted therapy.
DOI: 10.3389/fnins.2025.1591417PMID: 40421132
Implications of heart rate variability measured using wearable electrocardiogram devices in diagnosing Parkinson's disease and its association with neuroimaging biomarkers: a case-control study.
DOI: 10.3389/fnagi.2025.1530240PMID: 40421102
Leukoaraiosis does not impact motor outcomes in Parkinson's patients post deep brain stimulation.
DOI: 10.1016/j.prdoa.2025.100348PMID: 40487739
Sedation and sleep safety of pimavanserin for Parkinsons's disease psychosis: Review and exploratory analysis of clinical study data.
DOI: 10.1016/j.prdoa.2025.100342PMID: 40487740
Immunomodulatory natural polysaccharide-based nanoparticles for the treatment of neurodegenerative diseases.
DOI: 10.1002/ibra.12199PMID: 41018231
Real-world disease burden and planned treatment optimization after MANAGE-PD implementation in Germany: a cross-sectional study.
DOI: 10.1186/s42466-025-00383-2PMID: 40350459
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.